Interviews

Todd Semla, MS, PharmD, BCPS, FCCP, AGSF, National PBM Clinical Pharmacy Program Manager at the US Department of Veterans Affairs, discusses how to updated 2015 AGS Beers Criteria reflects new warnings about opioid use.

Todd Semla, MS, PharmD, BCPS, FCCP, AGSF, of the Department of Veterans Affairs explains how the AGS 2015 Beers Criteria will affect pharmacists' practice.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares what kinds of vaccinations pharmacists should expect to offer to their patients who travel abroad.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how the Pharmacy Disaster Support Center is different from similar centers.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some flaws of e-prescribing.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to controlled substance prescriptions.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some of the ways in which e-prescribing trumps traditional prescriptions.

Cheryl Allen, RPh, BSPharm, MBA, vice president of Industry Relations at Diplomat, discusses the services offered by Diplomat's HUB EnvoyHealth program.

Neil Friedman, COO of Bodimetrics, explains how pharmacists can best leverage the Bodimetrics Performance Monitor technology in their day-to-day practice.

After experiencing 18 hold-ups during his pharmacy career, James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses his past fears of going to work.

Tom Roark, PAHM, director of contract management at Diplomat, discusses the value contract management in specialty pharmacy operations.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, describes the current relationship between pharmacies and the DEA.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), provides an overview of some of the most important aspects of the Drug Quality and Security Act.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, describes the current relationship between pharmacies and the DEA.

Ryan Nolan, PharmD, MBA, CSP, clinical services manager at Diplomat, discusses how technology can be utilized to improve patient outcomes.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, talks about the 18 times he was burglarized over the course of his career.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses the integrated resource and support center and how it can help pharmacists with their contingency planning.

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses services offered by Diplomat's Hospital Specialty Program.

Neil Friedman, COO at Bodimetrics, describes the key functions and features of the Bodimetrics Performance Monitor.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.

Neil Friedman, COO at Bodimetrics, describes some of the key capabilities of the Bodimetrics Performance Monitor.

Cheryl Allen, RPh, BSPharm, MBA, vice president of Industry Relations at Diplomat, discusses how relationships can be improved between manufacturers, pharmacy benefit managers, and pharmacies.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), discusses what pharmacists need to know about the memorandum of understanding regarding the interstate shipment of compounds.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses the nuances between a pharmacist's method of intervention versus the practices of other health providers.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts several different innovative solutions that are poised to drive better medication adherence over the next 2-3 years.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how provider status would allow pharmacists to optimize their time and better support medication adherence for patients.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several ways in which Rite Aid demonstrates its commitment to the pharmacist's role in direct patient care.